Skip to main content

Ad Scientiam on TV Finance !

Liouma Tokitsu, Ad Scientiam CEO, and Alexis Génin, Head of research and technology development at the Brain and Spine Institute, were interviewed by TV Finance on July 12.

Ad Scientiam : the new digital medical monitoring

Ad Scientiam takes advantage of the smartphone’s 11+ sensors to allow patients continuous self-assessment and gathering useful informations for their health care.

The resulting applications are not gadgets but medical devices developed within a strict regulatory framework.

Ad Scientiam expands to Station F

Being the exclusive health partner of Station F, the iPEPS (the Brain and Spine Institute’s incubator) offers a unique ecosystem in Data Sciences, beyond the Institute innovative medical environment. These fantastic premises facilitate the emergence of the next-generation medtechs.

In addition to the clinical activities at the Brain and Spine Institute, Ad Scientiam continues its growth and develops its algorithm, data and signal processing center at Station F.

With these two expertises, the company aims to become a major player in patient-generated data and tackle the American market with offices in Seattle.  

To replay the interviews :

TV Finance :

Boursorama :

Latest News

Ad Scientiam solution, DAMS (Digital self-Assessment for Multiple Sclerosis), was awarded the Seal of Excellence by the European Commission at the Hor...

Driven by the wish to develop relevant and useful mobile applications, Ad Scientiam closely collaborates with patient advocacy groups at every step of...

Ad Scientiam launches its own validation clinical study on 200 patients in 10 Neurology centers specialized in Multiple Sclerosis

An article about Ad Scientiam and how new information and communication technologies impact healthcare. In French

Despite the innovation that could bring ResearchKit to clinical research, its use in France is currently limited. Indeed, legislation about clinical...

Ad Scientiam collaborates with researchers to improve our understanding about Attention Deficit Disorder with or without Hyperactivity.

Ad Scientiam collaborates with Dr. Mehran Firouzeh in a draft CEBT

Ad scientiam teams up with young researchers by supporting them during their study and by allowing them to have an access to its application.

Last april, Apple just launched a new promising tool for medical research : ResearchKit. This software is an open source framework which include...

The BRAiN’US project was born at the Brain and Spine Institute. The goal of the project is to gather information on how the brain really works.

Symptoms and side effects can be collected in real time from patients through their smartphone.


Ad Scientiam Research allows collecting data relative to asthma symptoms as often as required using the notification tool.


Ad Scientiam also contributes to sleep research by allowing data gathering in order to better understand our sleeping patterns.

Inclusion in cohorts

Ad Scientiam Research allows exploring small changes in environments and patient symptoms.


Ad Scientiam constructs tools for epidemiological studies regarding exercises / physical activities performed by obese patients.

Ad Scientiam is also concerned by the health of younger patients and has set as one of its objectives to promote sport and balanced diet.

In collaboration with a cardiology department and an engineering school, Ad Scientiam is developing an electronic aftercare telemonitoring solution...

Alcohol dependency

Patients can type in data concerning their alcohol usage and benefit from personalised help and follow up on their progress.

Patient compliance

Ad Scientiam is developing a solution allowing increasing patient answering rate as it coaches patients to improve answer rates to questions.

Parkinson's disease

Ad Scientiam contributes to research by gathering and analyzing data on Parkinson's symptom changes.

Addiction medicine

Understand and quantify the cannabis use on patient is an important step for addiction specialists.

Understanding Real World Data history